Why I’m Glad I Sold Tesco PLC, Vodafone Group plc And GlaxoSmithKline plc, And Why I’m Tempted To Buy Them Again

Harvey Jones shares the share prices are finally right at Tesco PLC (LON:TSCO), Vodafone Group plc (LON:VOD) and GlaxoSmithKline plc (LON:GSK)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The decision to sell a stock is just as tough as the decision to buy one. I am still cursing my decision to sell microchip manufacturer ARM Holdings, only to watch its value subsequently quadruple.

That was my worst ‘sell’ error, but by no means the last.

So I’m delighted to see the three stocks I have offloaded over the past year have suffered ever since, plunging by up to 25% since I dumped them.

In fact, they’ve done so badly, I’m tempted to buy them back again.

Ta Ta, Tesco

TescoI sold beleaguered supermarket giant Tesco (LSE: TSCO) (NASDAQOTH: TSCDY.US) in March for 326p, banking a small profit on my original purchase. I put a lot of thought into the decision, and I’m glad I called it right.

I was disappointed by Tesco’s failure to establish itself in the US, following the ‘Fresh & Easy’ debacle. With reversals in Korea and Thailand as well, I suspected Tesco had overreached.

At home, customers were also complaining about staff, stores, produce and prices, and openly confessing they preferred to shop at budget rivals Aldi and Lidl instead.

I feared Tesco’s size and scale was now working against it. This week’s news that the big supermarkets are ditching plans to build new megastores is vindication.

Ultimately, it’s the fact that Tesco’s share price has since plummeted to just 245p (and is still falling) that proves I was right to sell. I have spared myself a 25% share price plummet.

Auf Wiedersehen, Vodafone

vodIt’s never wrong to bank a profit, the saying goes, and I doubled my money in the five years I held Vodafone Group (LSE: VOD) (NYSE: VOD.US). 

Having offloaded its prize asset, Verizon Wireless, I suspected future performance might be somewhat anticlimactic, and I was right. I sold in March at 229p. If I bought Vodafone today, I would pay just 198p, or 13.5% less.

I was nervous that Vodafone would blow its Verizon windfall. Its £7 million Project Spring transformation programme certainly looked costly.

Another concern was that so much stuff is given away as freebies these days, particularly messaging services and apps, that Vodafone could struggle to monetise its offering.

Its exposure to a retrenching Europe also made me edgy.

Goodbye, Glaxo

GlaxoSmithKlineI was clearly feeling nervous about market prospects in March, because I also offloaded another long-term hold, pharma giant GlaxoSmithKline (LSE: GSK).

The Chinese bribery scandals had already been aired, and I feared they might intensify, as scandals have a habit of doing. And that’s exactly what has happened.

Flat earnings growth in 2012 and 2013, expiring drug patents, and sheer boredom also enticed me to sell. If I wanted something this dull, I might as well play safe and buy a FTSE 100 tracker, I thought.

So that’s what I did, selling at a price of 1,650p.

A little over four months later, it trades at 1,411p, a discount of 15%.

I Want You Back

All three stocks look more tempting at today’s prices. Tesco is now available at 7.8 times earnings, Vodafone at 11.2 times and Glaxo at 12.9 times. They yield 5.9%, 5.6% and 5.4% respectively.

The concerns I felt back in March haven’t gone away, but they are reflected in the new lower prices. And those yields are almost too juicy to miss.

The decision to buy is looking almost as straightforward as my decision to sell. Let’s hope it is as successful.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool has recommended GlaxoSmithKline and Vodafone. The Motley Fool owns shares of Tesco.

More on Investing Articles

Happy African American Man Hugging New Car In Auto Dealership
Investing Articles

Will 2025 be make or break for this FTSE 250 stock hitting the headlines?

One of the FTSE 250's worst performers in 2024 has just issued another profit warning, but could 2025 mark the…

Read more »

Investing Articles

£3,000 invested in Greggs shares three months ago is worth this much now

Harvey Jones was on the verge of buying Greggs shares in August but decided they looked a little pricey. So…

Read more »

Investing Articles

After rising a stunning 97% is this FTSE star still my best share to buy today?

This time last year Harvey Jones declared FTSE 100 data analytics firm RELX to be the best share to buy.…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

2 top growth stocks I’m buying in December… before it’s too late

When it comes to growth stocks, Stephen Wright thinks rising prices are limiting opportunities right now. But it’s quality, not…

Read more »

A front-view shot of a multi-ethnic family with two children walking down a city street on a cold December night.
Investing Articles

2 top dividend shares to consider buying in December

When it comes to passive income in December, Stephen Wright's targeting shares in companies focused on paying dividends to investors.

Read more »

Man smiling and working on laptop
Investing Articles

£20,000 in savings? Here’s how Stocks and Shares ISA investors could target a near-£2,000 monthly income

Investing a lump sum in this investment trust could help Stocks and Shares ISA investors make mammoth returns, says Royston…

Read more »

Dividend Shares

3 crucial factors for building my passive income

Ken Hall wants to build a passive income that can set him up for years to come. Here are three…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

Surprise! This monopoly stock has taken over my Stocks and Shares ISA (again)

Our writer has a (nice) dilemma in his Stocks and Shares ISA portfolio after one incredible growth stock rocketed higher…

Read more »